Is Baxter International an Underrated Healthcare Investment Play?

Baxter International sells medical products and devices. The company's products are necessities for the healthcare industry.

The Motley Fool • 20 hours ago

Reasons to Retain Baxter International Stock in Your Portfolio Now

BAX is reshaping its portfolio following the divestiture of its Kidney Care business, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum.

Zacks Investment Research • Jan 28, 2026

Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at.

Business Wire • Jan 21, 2026

The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt

Baxter International offers a compelling defensive play, trading at historically low valuations after significant deleveraging and operational headwinds. BAX's forward cash earnings multiple is around 8x, notably cheaper than hospital and consumer health product peers, despite slightly weaker gross profit margins. Management's focus on debt reduction and cost controls positions BAX for margin expansion and potential sales growth into 2027.

Seeking Alpha • Jan 17, 2026

Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety

BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.

Zacks Investment Research • Jan 14, 2026

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

DEERFIELD, Ill.--(BUSINESS WIRE)--BAXTER INTRODUCES THE DYNAMO SERIES, A NEW SMART STRETCHER TO HELP ADDRESS COMMON CHALLENGES IN HOSPITAL SETTINGS.

Business Wire • Jan 13, 2026

Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 13, 2026

MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

CHARLESTON, S.C.--(BUSINESS WIRE)--MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care already delivered at MUSC Health, MUSC's health care system, through integrated connected care technologies. By leveraging Baxter's cutting-edge solutions and MUSC Health's clinical and academic expertise, the partnership aims to help drive further improvements in nurse s.

Business Wire • Jan 8, 2026

Baxter to Present at J.P. Morgan 2026 Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, Baxter's president and chief executive officer, is scheduled to present at 2:15 p.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, July 11, 2026. About Baxter At Baxter, we are everywhere healthcare happen.

Business Wire • Jan 6, 2026

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Baxter International, Inc. (NYSE: BAX) and Molina Healthcare, Inc. (NYSE: MOH) on behalf of long-term stockholders. More information about each potential case can be found at the link provided.

GlobeNewsWire • Dec 16, 2025